EconomyNovartis bets on bigger blockbusters to drive growth, forecasts 5% annual sales growth through 2031
Novartis cited strong demand for its blockbuster medicines as it raised peak-sales forecasts for drugs treating multiple sclerosis, leukemia and high cholesterol. It expects annual sales to grow 5% through 2031.
Novartis bets on bigger blockbusters to drive growth, forecasts 5% annual sales growth through 2031
Economy